Brief: Janux Therapeutics Q1 collaboration revenue USD 2.048 million
09/05/2023 22:09
May 9 (Reuters) - Janux Therapeutics Q1 operating income USD -20.281 million. * Q1 net income USD -17.459 million * Q1 basic EPS USD -0.42 * Q1 operating expenses USD 22.329 million * Q1 collaboration revenue USD 2.048 million